Research
Hormonal
Combinations of GLP-1 RA, GIP, and glucagon RA (retatrutide) have shown weight loss efficacy approaching that of bariatric surgery.
Combination therapies may offer significant weight loss benefits similar to surgical options.
StrongSupportsmedium confidence
Notably, the combinations of GLP-1 RA, GIP and glucagon RA (retatrutide) have shown WL efficacy closing on to that observed in bariatric surgery.
Why this rating
The claim is based on promising data from clinical trials.
Source
Glucagon-like peptide-1 receptor analogues and beyond: emerging obesity pharmacotherapies
Kaivalya Abburi et al. · Panminerva Medica · 2025
review
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →